On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

AstraZeneca (United States)

InstitutionResearch output, impact & collaborations

AstraZeneca (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about AstraZeneca (United States)?

ScholarIQrecord summary

AstraZeneca (United States) is a research organisation in Wilmington, US. OpenAlex records 11,565 works and 1,310,146 citations for it. 3,279 researchers list it as their most recent affiliation.

How many works does AstraZeneca (United States) have?

ScholarIQindexed works

AstraZeneca (United States) has 11,565 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for AstraZeneca (United States) →

How many citations does AstraZeneca (United States) have?

ScholarIQcitation count

AstraZeneca (United States) has 1,310,146 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for AstraZeneca (United States) →

How many researchers are at AstraZeneca (United States)?

ScholarIQresearcher count

AstraZeneca (United States) has 3,279 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at AstraZeneca (United States)?

ScholarIQavg h-index

AstraZeneca (United States) has an average h-index of 44.5 in OpenAlex.

Open the OpenAlex record →

What is the ROR of AstraZeneca (United States)?

ScholarIQror

The ROR for AstraZeneca (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for AstraZeneca (United States)?

ScholarIQopenalex

The OpenAlex for AstraZeneca (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind AstraZeneca (United States)?

ScholarIQtop researchers by citations

J. Carl Barrett · Cancer Genomics and Diagnostics

572 works39,328 citations

Arthur Liberzon · Bioinformatics and Genomic Networks

29 works28,194 citations

David E. Tabor · Respiratory viral infections research

67 works24,074 citations

Juliann Chmielecki · Lung Cancer Treatments and Mutations

376 works23,985 citations

Chintan Parmar · Radiomics and Machine Learning in Medical Imaging

68 works23,496 citations

What are the most-cited papers on AstraZeneca (United States)?

ScholarIQmost cited works

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

Hugo J.W.L. Aerts, Emmanuel Rios Velazquez, Ralph T. H. Leijenaar, Chintan Parmar, Patrick Großmann, Sara Carvalho, Johan Bussink, René Monshouwer, Benjamin Haibe‐Kains, D. Rietveld, Frank Hoebers, Michelle M. Rietbergen, C. René Leemans, André Dekker, John Quackenbush, Robert J. Gillies, Philippe Lambin

Nature Communications. 20145,209 CitationsOPEN ACCESS

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Andrew S. Levey, Kai‐Uwe Eckardt, Yusuke Tsukamoto, Adeera Levin, Josef Coresh, Jérôme Rossert, Dick de Zeeuw, Thomas H. Hostetter, Norbert Lameire, Garabed Eknoyan

Kidney International. 20053,953 CitationsOPEN ACCESS

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

Zachary R. Chalmers, Caitlin Connelly, David Fabrizio, Laurie M. Gay, Siraj M. Ali, Riley Ennis, Alexa B. Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin W. Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi A. Garraway, Vincent A. Miller, P. J. Stephens, Garrett M. Frampton

Genome Medicine. 20173,771 CitationsOPEN ACCESS

Olaparib for Metastatic Castration-Resistant Prostate Cancer

Johann S. de Bono, Joaquı́n Mateo, Karim Fizazi, Fred Saad, Neal D. Shore, Shahneen Sandhu, Kim N., Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Niven Mehra, Carsten Goessl, Jinyu Kang, Joseph E. Burgents, Wenting Wu, Alexander Kohlmann, Carrie A. Adelman, Maha Hussain

New England Journal of Medicine. 20202,278 CitationsOPEN ACCESS

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip, Byoung Chul Cho, Daniel Stetson, Brian Dougherty, Zhongwu Lai, Aleksandra Markovets, Ana Vivancos, Yanan Kuang, Dalia Ercan, Sarah E Matthews, Mireille Cantarini, J. Carl Barrett, Pasi A. Jänne, Geoffrey R. Oxnard

Nature Medicine. 20151,558 CitationsOPEN ACCESS

How much of the research on AstraZeneca (United States) is open access?

ScholarIQopen access share

83%OPEN ACCESS

Gold

Green

17%

Hybrid

Bronze

50%

Closed

17%